WinstonWınston
Back
Mediclin AG logo

Mediclin AG

MED.DE
57
Medical - Care Facilities · Healthcare
Exchange
Frankfurt Stock Exchange
Winston Score
57
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Strong
Stability
Strong
Valuation
Exceptional
Dividends
Weak

Winston Score History

The full picture

MediClin AG is a German healthcare company that runs hospitals, rehabilitation clinics, and nursing care facilities. It serves patients who need medical treatment, recovery care after surgery or illness, and long-term nursing support. The company operates across Germany and is one of the mid-sized private hospital and rehabilitation groups in the country.

MediClin makes money by providing healthcare services, with revenue coming mainly from payments by German public health insurers and private insurers on behalf of patients. The company operates entirely within Germany, with around 8,000 employees and roughly 30 facilities. Its position within Germany's tightly regulated healthcare system provides some stability, since reimbursement rates are set by government bodies rather than open-market competition. However, the main risk the business faces is cost pressure — rising staff wages and energy costs are squeezing margins, as reflected in its relatively thin operating margin of around 6%, leaving little room for error if reimbursement rates do not keep pace with inflation.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+0.3% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+5.0% YoY

YoY Growth Rate

Slow EPS growth

Insider Activity

87.7%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

€96M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Mediclin AG is growing revenue at 0% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
13.0%
Thin — 13.0% gross margin
Profit after running costs
Operating Margin
8.7%
Modest — 8.7% operating margin
Return on the money invested
ROCE
16.0%
Strong — 16.0% return on capital

ROIC between 15% and 25%. Every dollar invested in the business earns 15 to 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+2.9%
Nearly flat sales (+2.9% YoY)
Profit growth
EPS YoY
-12.7%
Earnings shrinking (-12.7% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

How steady the profit is
EPS Consistency
7/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
318%
Turns 318% of profit into real cash
Spare cash per sale
FCF Margin
6.6%
Modest free cash flow (6.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.16
Conservative — low debt load (0.16)
Covers its interest
Interest Cover
2.50x
Tight — interest eats into profit (2.5x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
8.2x
no trend
Attractive valuation — P/E 8.2

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
+3.8
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (8.2 → 4.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
0.99%
no trend
Small dividend — 0.99% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
-28.0%
no trend
Dividend cut (-28.0% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial